Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS EQUITY (DEFICIT) (Details 4)

v3.24.0.1
STOCKHOLDERS EQUITY (DEFICIT) (Details 4)
12 Months Ended
Dec. 31, 2023
$ / shares
shares
Number of exercisable options 244,749
Weighted average exercise price exercisable | $ / shares $ 35.52
Registered Warrant | 33  
Exercise price range 5.50
Number of exercisable Register warrant 495,917
Number of exercisable options 495,917
Weighted average exercise price exercisable term 2 years 4 months 24 days
Weighted average exercise price exercisable | $ / shares $ 33.00